{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:14:00Z","timestamp":1790295240617,"version":"4.1.0"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,12,2]]},"published-print":{"date-parts":[[2025,2]]},"DOI":"10.2967\/jnumed.124.268877","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:00:17Z","timestamp":1737046817000},"page":"257-263","source":"Crossref","is-referenced-by-count":9,"title":["Safety, Biodistribution, and Radiation Dosimetry of the\n                    <sup>68<\/sup>\n                    Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors"],"prefix":"10.2967","volume":"66","author":[{"given":"Elisabeth","family":"von Guggenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"di Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Uprimny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Bayerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Warwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton A.","family":"H\u00f6rmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraneh S.","family":"Zavvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rangger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Decristoforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sviridenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Nilica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene J.","family":"Virgolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"2025020306150624000_66.2.257.1","first-page":"1377","article-title":"Cholecystokinin (CCK)-A and CCK-B\/gastrin receptors in human tumors","volume":"57","author":"Reubi","year":"1997","journal-title":"Cancer Res."},{"key":"2025020306150624000_66.2.257.2","first-page":"63","article-title":"Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"41","author":"Reubi","year":"1997","journal-title":"Q J Nucl Med."},{"key":"2025020306150624000_66.2.257.3","doi-asserted-by":"publisher","DOI":"10.2174\/156802607780960546"},{"key":"2025020306150624000_66.2.257.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.10.010"},{"key":"2025020306150624000_66.2.257.5","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.3390\/cancers13225776","article-title":"Update on preclinical development and clinical translation of cholecystokinin-2 teceptor targeting radiopharmaceuticals","volume":"13","author":"von Guggenberg","year":"2021","journal-title":"Cancers."},{"key":"2025020306150624000_66.2.257.6","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.2174\/0929867327666200625143035","article-title":"Cholecystokinin-2 receptor targeting with radiolabeled peptides: current status and future directions","volume":"27","author":"Klingler","year":"2020","journal-title":"Curr Med Chem."},{"key":"2025020306150624000_66.2.257.7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00726-010-0501-y","article-title":"Radiolabeled CCK\/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors","volume":"41","author":"Roosenburg","year":"2011","journal-title":"Amino Acids."},{"key":"2025020306150624000_66.2.257.8","doi-asserted-by":"publisher","DOI":"10.1002\/bip.10356"},{"key":"2025020306150624000_66.2.257.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2008.09.006"},{"key":"2025020306150624000_66.2.257.10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s00259-022-05992-6","article-title":"[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC phase I clinical trial","volume":"50","author":"Lezaic","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025020306150624000_66.2.257.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233031"},{"key":"2025020306150624000_66.2.257.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.221283"},{"key":"2025020306150624000_66.2.257.13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00259-020-04963-z","article-title":"Comparison of PET\/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma","volume":"48","author":"Uprimny","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025020306150624000_66.2.257.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264977"},{"key":"2025020306150624000_66.2.257.15","doi-asserted-by":"publisher","DOI":"10.1002\/jca.2920030313"},{"key":"2025020306150624000_66.2.257.16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/ph14060575","article-title":"Radiopharmaceutical formulation and preclinical testing of 68Ga-labeled DOTA-MGS5 for the regulatory approval of a first exploratory clinical trial","volume":"14","author":"H\u00f6rmann","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"key":"2025020306150624000_66.2.257.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.056036"},{"key":"2025020306150624000_66.2.257.18","doi-asserted-by":"publisher","DOI":"10.1021\/jm101279a"},{"key":"2025020306150624000_66.2.257.19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5603\/EP.2016.0010","article-title":"Medullary thyroid carcinoma: PET\/CT imaging with 68Ga-labelled gastrin and somatostatin analogues","volume":"67","author":"Kunikowska","year":"2016","journal-title":"Endokrynol Pol."},{"key":"2025020306150624000_66.2.257.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1098-9"},{"key":"2025020306150624000_66.2.257.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.238808"},{"key":"2025020306150624000_66.2.257.22","first-page":"52","article-title":"Preliminary experience with 68Ga-DOTA-lanreotide positron emission tomography","volume":"54","author":"Traub-Weidinger","year":"2010","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2025020306150624000_66.2.257.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1512-3"},{"key":"2025020306150624000_66.2.257.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.120600"},{"key":"2025020306150624000_66.2.257.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.114165"},{"key":"2025020306150624000_66.2.257.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70801-4"},{"key":"2025020306150624000_66.2.257.27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/RLU.0000000000005355","article-title":"Biodistribution and radiation dosimetry for 68Ga-DOTA-CCK-66, a novel CCK2R-targeting compound for imaging of medullary thyroid cancer","volume":"49","author":"Viering","year":"2024","journal-title":"Clin Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:17:03Z","timestamp":1738574223000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.2967\/jnumed.124.268877"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268877","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}